Who Paid My Doc
Ranil Ninala
Occupational Medicine Dallas, TX Medical Doctor
NPI 1831219658 CMS profile 671826
6612 Harry Hines Blvd, Dallas, TX 75235
General payments
$165
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Ranil Ninala of Dallas, TX is reported in the CMS Open Payments database as having received $165 across 4 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 68th percentile of Occupational Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1 | 1 | |
| 2024 | General | $33 | 2 | |
| 2023 | General | $131 | 1 |
Beside peers
- Ranil Ninala
- Occupational Medicine median
- Middle half of Occupational Medicine
- National median
In program year 2025, general payments to Ranil Ninala were reported at $1. Among 219 Occupational Medicine profiles paid that year, the median was $54 and the middle half received between $24 and $162.
Show as a table
| Year | Ranil Ninala | Occupational Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $59 | $18–$204 | $163 |
| 2020 | $0 | $49 | $21–$288 | $114 |
| 2021 | $0 | $56 | $22–$204 | $132 |
| 2022 | $0 | $83 | $24–$209 | $149 |
| 2023 | $131 | $71 | $25–$185 | $160 |
| 2024 | $33 | $77 | $26–$205 | $164 |
| 2025 | $1 | $54 | $24–$162 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 7 drugsPart D claims
222
Drug cost
$3,834
Branded share of claims
52.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 100 | $2,829 | |
| Amitriptyline Hcl | Generic | 13 | $551 | |
| Alprazolam | Generic | 12 | $201 | |
| Tramadol Hcl | Generic | 38 | $98 | |
| Cyclobenzaprine Hcl | Generic | 31 | $89 | |
| Acetaminophen-Codeine Acetaminophen With Codeine | Brand | 16 | $53 | |
| Meloxicam | Generic | 12 | $14 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 584 Part D prescribers listed as Preventive Medicine; they describe a distribution and say nothing about conduct.
Records
4 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Occupational Medicine in Texas
Admerle Hall-Hoskins
Occupational Medicine · Plano, TX
Ronald Moomaw
Occupational Medicine · Plano, TX
Simone Willingham
Occupational Medicine · Houston, TX
George Warren
Occupational Medicine · Plano, TX
Guy Racette
Occupational Medicine · Corpus Christi, TX
Rosa Belena Bruce
Occupational Medicine · Pasadena, TX
Related records
Occupational Medicine in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Occupational Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.